Results 251 to 260 of about 98,021 (296)
Some of the next articles are maybe not open access.
Pneumonia in the immunocompromised host
Current Opinion in Pulmonary Medicine, 2014Novel treatment modalities for previously fatal diseases, including newer chemotherapeutic and biologic agents and the expansion of the indications for solid organ and stem cell transplantation, have resulted in prolonged patient survival and a significant increase in the population of immunocompromised hosts (ICHs).This review discusses the increasing
Alyssa R, Letourneau +2 more
openaire +2 more sources
Travel and the immunocompromised host
Hospital Medicine, 2000Increasing opportunities for travel and advances in medicine mean that immunocompromised patients may venture to potentially risky parts of the world. This article examines the risks faced by such travellers. Some limitations of standard travel vaccines are discussed and suggestions are made as to how best to advise such travellers.
openaire +2 more sources
Vaccination of the immunocompromised host
Wiener Medizinische Wochenschrift, 2004Vaccinations are safe and effective in immunocompromised patients. Apparently most vaccines in this patient population are underutilized. General vaccination recommendations are expressed for influenza, diphtheria and tetanus. Pneumococcal, meningococcal und Haemophilus influenzae B immunizations are specially indicated for patients with or developing ...
Andrew J, Ullmann +2 more
openaire +2 more sources
Sinusitis in the immunocompromised host
Current Infectious Disease Reports, 1999Sinusitis occurs in a wide range of immunocompromised hosts, including neutropenic patients, diabetic patients, patients in critical care units, and patients with HIV infection. Reversal of underlying risk factors, such as neutropenia or diabetic ketoacidosis, is essential in the treatment of fungal rhinosinusitis.
openaire +2 more sources
Madurella infection in an immunocompromised host
International Journal of Dermatology, 2000A 77‐year‐old farmer, born and living in Sardinia, affected by acute myelogenous leukemia and undergoing chemotherapy treatment with cytosine arabinoside, presented at the Institute of Dermatology of Sassari in March 1998 with multiple subcutaneous lesions on the legs (Fig. 1) which had appeared 3 months previously.
SATTA, Rosanna Rita, Sanna S, Cottoni F.
openaire +3 more sources
Emphysematous gastritis in an immunocompromised host
Clinical Imaging, 1995Emphysematous gastritis is a rare, often lethal condition of gastric mural inflammation and gaseous dissection. Infection with gas-forming organisms is the most frequently cited cause. In all previously reported patients, the clinical presentation was dramatic. We report on an immunocompromised host who had a surprisingly subtle clinical presentation.
Richard J Van Allan, T L Krebs
exaly +3 more sources
Update on Strongyloidiasis in the Immunocompromised Host
Current Infectious Disease Reports, 2010Immunocompromised persons are the most vulnerable population at risk for developing life-threatening clinical syndromes associated with strongyloidiasis, such as hyperinfection syndrome (HS) or dissemination. This review focuses on describing Strongyloides infection in the immunocompromised host, including immune response against this infection ...
Luis A Marcos +2 more
exaly +3 more sources
Management of the Immunocompromised Host
Medical Clinics of North America, 1984This article deals with the management of the immunocompromised host. Mechanisms of immunocompromise include alterations in skin and mucosal barriers, normal oral and intestinal flora, splenic function, and number or function of T cells, B cells, granulocytes, and monocytes.
openaire +2 more sources
[An immunocompromised host with a fever].
Nederlands tijdschrift voor geneeskunde, 2010A 61-year-old woman with a hepatocellular carcinoma was admitted to the hospital for transplantation of the liver. She had a compromised immune system and developed a aspergillus pneumonia. The patient eventually died due to sepsis and multiple organ failure.
Witjes, Carlijn, Kazemier, G
openaire +2 more sources
Lung biopsy in immunocompromised hosts
The American Journal of Medicine, 1975Ninety-five lung biopsy procedures in 78 immunocompromised patients yielded treatable diagnoses in 35 per cent of the needle aspirates, 46 per cent of the cutting needle biopsies and 65 per cent of the open thoracotomies. Complication rates of bleeding or pneumothorax were comparable to those previously described in nonimmunocompromised patients.
R L, Greenman, P T, Goodall, D, King
openaire +2 more sources